Walgreens to sell CBD products in 1,500 stores

Walgreen.jpg

  • Walgreens will sell CBD creams, patches and sprays in nearly 1,500 stores in select states.
  • Walgreens will sell the cannabis-based products in Oregon, Colorado, New Mexico, Kentucky, Tennessee, Vermont, South Carolina, Illinois and Indiana.
  • Rival drugstore chain CVS introduced CBD-containing topicals, including creams and salves, to stores in eight states earlier in March.

Walgreens will sell CBD creams, patches and sprays in nearly 1,500 stores in select states, the company told CNBC on Wednesday.

The drugstore chain will sell the cannabis-based products in Oregon, Colorado, New Mexico, Kentucky, Tennessee, Vermont, South Carolina, Illinois and Indiana. Walgreens declined to specify which brands it would carry.

“This product offering is in line with our efforts to provide a wider range of accessible health and wellbeing products and services to best meet the needs and preferences of our customers,” Walgreens spokesman Brian Faith said in an email.

Rival drugstore chain CVS introduced CBD-containing topicals, including creams and salves, to stores in eight states earlier in March. As the non-psychoactive cannabis compound becomes one of the hottest ingredients in consumer products, retailers are carefully evaluating the market.

Consumers are increasingly curious about CBD, which promises to help everything from anxiety to pain even though there is scant evidence backing up these claims. And while CBD derived from hemp is now legal thanks to the farm bill Congress passed late last year, the FDA says companies still can’t add CBD to food or sell it as a dietary supplement.

The regulatory uncertainty has left some large companies on the sidelines for now. Selling CBD-infused beauty and skin-care products brings far less risk, making it an obvious first step for retailers.

Here’s What Medical Cannabis Looks Like in Texas

Compassionate Cultivation founder and CEO Morris Denton looks over marijuana plants in the company’s flowering room in Manchaca, Texas.

Nearly all forms of cannabis are illegal in Texas. And by illegal, I mean very illegal. Possession of a small amount of cannabis concentrate—what we in the legal states know as a $30 vape cartridge—is a felony in the Lone Star State.

Medical marijuana here has almost no THC. It’s actually lower in THC than hemp-derived CBD.
But there is one form of cannabis that is allowed. It’s a highly specialized cannabidiol oil that contains, by law, no more than 0.5% THC and no less than 10% CBD. It’s available only to patients with intractable epilepsy, and three companies are licensed to produce and distribute it.

DEA moves some CBD medicines off Schedule 1, a limited expansion of cannabis access

A sheet of cannabis marijuana in the defocus with the image of the formula CBD

The U.S. Drug Enforcement Administration has taken some cannabidiol out of the most restrictive class of controlled substances, a move that allows the sale of the first nonsynthetic, cannabis-derived medicine to win federal approval.

It’s a decision that immediately affects CBD producers but also signals the agency’s first admission that the plant has medical value.

The DEA announced Thursday that drugs including CBD with THC content below 0.1% are now considered Schedule 5 drugs, as long as they have been approved by the U.S. Food and Drug Administration.

It is the first time the agency has lowered any type of cannabis from Schedule 1.

Continue reading “DEA moves some CBD medicines off Schedule 1, a limited expansion of cannabis access”

A Patient’s Guide to Using Cannabis for Cancer

Cannabis-Cancer-and-Compassion-01

The cannabis plant contains a number of compounds with research-backed benefits for cancer patients. The science-based case that it is a safe and effective medicine will be made below, with plenty of links to double-blind studies, authoritative sources, and leading experts. The takeaway being that the plant and preparations derived from it can provide relief of cancer-related symptoms like pain, nausea, and inflammation. Some research has even shown that some cannabis compounds may slow cancer growth and shrink tumors.

Continue reading “A Patient’s Guide to Using Cannabis for Cancer”

Cannabis for Post-Traumatic Stress Disorder: A Neurobiological Approach to Treatment

GB_USA_16_0037

The endocannabinoid system is intricately involved in regulation of the neurobiological processes, which underlie the symptomatology of posttraumatic stress disorder (PTSD).

This article discusses the neurobiological underpinnings of PTSD and the use of cannabis for treating PTSD in the New Mexico Medical Cannabis Program.1

Continue reading “Cannabis for Post-Traumatic Stress Disorder: A Neurobiological Approach to Treatment”

A Primer About Cannabidiol And The Benefits Of CBD

cbddd

Many of cannabinoids have therapeutic value and CBD is no exception.

Scientists are rapidly discovering more and more about the rather amazing abilities of the cannabinoids found in the cannabis plant. Most of them have shown therapeutic value, as have the terpenes, which give the plant its distinct odors. There are over 125 terpenes and over 80 cannabinoids in cannabis and each strain has its own unique blend that create its distinct effects.

CBD is just one cannabinoid. Cannabinoids are 21-carbon molecules that block or stimulate endocannabinoid receptors. It’s known that other cannabinoids, such as THC, THCV, CBN and CBD, bind to CB1 and/or CB2 receptors, just as do the brain’s own naturally occurring cannabinoids – AEA and 2 AG.

Many of these cannabinoids have therapeutic value and CBD is no exception. It is a non-psychotropic cannabinoid, meaning it does not contribute to the euphoria associated with certain strains of cannabis. It is, however, psychoactive, because it crosses the blood-brain barrier. Unlike THC, CBD can be administered at relatively high doses without undesired psychological side effects.

Continue reading “A Primer About Cannabidiol And The Benefits Of CBD”

For Baby Boomers, 2018 Was The Year Of CBD. Get Ready For 2019

cbdizzle

2018 was the year CBD was on everyone’s lips, thanks to plenty of media buzz and the suddenly-ubiquitous presence of an array of CBD-infused beverages, lotions and self-care products. It was also the year “CBD gummies” reached No. 3 on Google’s most popular search terms. And I’m willing to go out on a limb that a significant portion of those searches were made by Baby Boomers.

Cannabidiol (CBD), a non-intoxicating compound found in cannabis, is being touted as a natural remedy for chronic pain, insomnia, depression and anxiety, among other conditions. The research to prove CBD’s therapeutic outcomes is still largely forthcoming. But even without the science, it’s no wonder that adults over 50, who suffer most from these conditions, are behind one of the fastest growing market segments for CBD products.

Continue reading “For Baby Boomers, 2018 Was The Year Of CBD. Get Ready For 2019”